Skip to main content

Closed

SLN: Silence Therapeutics plc Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

79thpctl

Volume

1.34×avg

Market Cap

495.48MUSD

P/E Ratio

-2.4TTM

Div Yield

-ann

Silence Therapeutics plc

SLNNASDAQ Global Market·USD·Closed

Silence Therapeutics plc

SLNNASDAQ·USD·Closed

$10.49

−9.72%

$10.49

−$1.13 (9.72%)

52W Range

79thpctl

Volume

1.34×avg

Mkt Cap

495.48MUSD

P/E

-2.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings